Chargement en cours...
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
BACKGROUND: Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may suffer recurrent exacerbations with an increase in volume or purulence of sputum, or both. Personal and healthcare costs associated with exacerbations indicate that therapies that reduce the occurrenc...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2019
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527426/ https://ncbi.nlm.nih.gov/pubmed/31107966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001287.pub6 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|